154 related articles for article (PubMed ID: 38232804)
1. Silicon-Based Piezo Micropumps Enable Fully Flexible Drug Delivery Patterns.
Plano D; Kibler S; Rudolph N; Zett O; Dressman J
J Pharm Sci; 2024 Jun; 113(6):1555-1565. PubMed ID: 38232804
[TBL] [Abstract][Full Text] [Related]
2. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
[TBL] [Abstract][Full Text] [Related]
3. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
[TBL] [Abstract][Full Text] [Related]
4. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
Kunnath K; Huang Z; Chen L; Zheng K; Davé R
Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
[TBL] [Abstract][Full Text] [Related]
5. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers.
Ha JU; Xanthos M
Int J Pharm; 2011 Jul; 414(1-2):321-31. PubMed ID: 21601624
[TBL] [Abstract][Full Text] [Related]
6. Jet milling industrialization of sticky active pharmaceutical ingredient using quality-by-design approach.
Nakach M; Authelin JR; Corsini C; Gianola G
Pharm Dev Technol; 2019 Sep; 24(7):849-863. PubMed ID: 30998419
[TBL] [Abstract][Full Text] [Related]
7. Prilling of API/fatty acid suspensions: Processability and characterisation.
De Coninck E; Vanhoorne V; Elmahdy A; Boone M; Van Assche G; Markl D; De Geest BG; De Beer T; Vervaet C
Int J Pharm; 2019 Dec; 572():118756. PubMed ID: 31648017
[TBL] [Abstract][Full Text] [Related]
8. [Analysis and test of piezoelectric micropump for drug delivery].
Kan J; Xuan M; Yang Z; Wu Y; Wu B; Cheng G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):809-13. PubMed ID: 16156279
[TBL] [Abstract][Full Text] [Related]
9. Importance of Propellants and Excipients in Pharmaceutical Topical Aerosol.
Patra M; Bhattacharya S; Patnaik M
Curr Drug Deliv; 2017; 14(8):1106-1113. PubMed ID: 28290242
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
[TBL] [Abstract][Full Text] [Related]
11. Examining drug hydrophobicity in continuous wet granulation within a twin screw extruder.
Li H; Thompson MR; O'Donnell KP
Int J Pharm; 2015 Dec; 496(1):3-11. PubMed ID: 26232701
[TBL] [Abstract][Full Text] [Related]
12. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional porous silicon for therapeutic drug delivery and imaging.
Santos HA; Bimbo LM; Lehto VP; Airaksinen AJ; Salonen J; Hirvonen J
Curr Drug Discov Technol; 2011 Sep; 8(3):228-49. PubMed ID: 21291407
[TBL] [Abstract][Full Text] [Related]
14. Formulation strategy and use of excipients in pulmonary drug delivery.
Pilcer G; Amighi K
Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
[TBL] [Abstract][Full Text] [Related]
15. Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions.
Bao Q; Zou Y; Wang Y; Choi S; Burgess DJ
AAPS J; 2021 Mar; 23(2):42. PubMed ID: 33709196
[TBL] [Abstract][Full Text] [Related]
16. Acoustofluidic Based Wireless Micropump for Portable Drug Delivery Applications
You R; Fu X; Duan X
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1276-1279. PubMed ID: 34891518
[TBL] [Abstract][Full Text] [Related]
17. Local arterial wall drug delivery using balloon catheter system.
Tesfamariam B
J Control Release; 2016 Sep; 238():149-156. PubMed ID: 27473765
[TBL] [Abstract][Full Text] [Related]
18. Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads.
Fan C; Pai-Thakur R; Phuapradit W; Zhang L; Tian H; Malick W; Shah N; Kislalioglu MS
Eur J Pharm Sci; 2009 Apr; 37(1):1-10. PubMed ID: 19027852
[TBL] [Abstract][Full Text] [Related]
19. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
Casas M; Aguilar-de-Leyva Á; Caraballo I
Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
[TBL] [Abstract][Full Text] [Related]
20. Towards rational design of API-poly(D, L-lactide-co-glycolide) based micro- and nanoparticles: The role of API-polymer compatibility prediction.
Iemtsev A; Zumaya ALV; Dinh M; Hassouna F; Fulem M
Int J Pharm; 2024 Jan; 650():123724. PubMed ID: 38123107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
